http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 25 Jun 2024 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+21++Filed+by%3A+Mills+C+Randal/23393205.html si-local-file:///var/storage/secattach/20240625/23393205.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+21++Filed+by%3A+Mills+C+Randal/23393205.html Tue, 25 Jun 2024 08:30:00 -0400 AZYO O.31701438 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+21++Filed+by%3A+Mills+C+Randal/23393205.html si-local-file:///var/storage/secattach/20240625/23393205.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+21++Filed+by%3A+Mills+C+Randal/23393205.html Tue, 25 Jun 2024 08:30:00 -0400 AZYO O.31701438 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+16/23372529.html si-local-file:///var/storage/secattach/20240618/23372529.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+16/23372529.html Tue, 18 Jun 2024 16:16:00 -0400 AZYO O.31701438 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+16/23372529.html si-local-file:///var/storage/secattach/20240618/23372529.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+16/23372529.html Tue, 18 Jun 2024 16:16:00 -0400 AZYO O.31701438 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ELUTIA+INC.++++++++++++++++++++++++++/23364255.html si-local-file:///var/storage/secattach/20240617/23364255.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ELUTIA+INC.++++++++++++++++++++++++++/23364255.html Mon, 17 Jun 2024 08:30:00 -0400 AZYO O.31701438 http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ELUTIA+INC.++++++++++++++++++++++++++/23364255.html si-local-file:///var/storage/secattach/20240617/23364255.html http://www.streetinsider.com/SEC+Filings/Form++424B5++++++ELUTIA+INC.++++++++++++++++++++++++++/23364255.html Mon, 17 Jun 2024 08:30:00 -0400 AZYO O.31701438 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+14/23364172.html si-local-file:///var/storage/secattach/20240617/23364172.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+14/23364172.html Mon, 17 Jun 2024 08:16:00 -0400 AZYO O.31701438 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+14/23364172.html si-local-file:///var/storage/secattach/20240617/23364172.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+14/23364172.html Mon, 17 Jun 2024 08:16:00 -0400 AZYO O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Press+Releases/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 3,175,000 shares of the Company’s Class A common stock at a purchase price of $3.40 per share and 725,000 prefunded warrants to purchase up to 725,000 shares of the Company’s Class A common stock at a purchase price of $3.399 per prefunded warrant in a registered direct offering. The prefunded warrants are immediately exercisable at an exercise price of $0.001 per each prefunded http://www.streetinsider.com/Globe+Newswire/Elutia+Announces+%2413.26+Million+Registered+Direct+Offering/23364072.html Mon, 17 Jun 2024 08:01:00 -0400 A.09642568 AZYO ELUT O.20371933 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html <p align="center"><em>EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market</em><br/></p> <p align="center"><em>EluPro also granted clearance for indications beyond CIEDs, including neurostimulators and neuromodulators used for pain management, epilepsy, incontinence, and sleep apnea</em></p> <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA). http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html Mon, 17 Jun 2024 08:00:00 -0400 A.03607790 A.06822034 AZYO ELUT O.20026344 O.20147506 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html <p align="center"><em>EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market</em><br/></p> <p align="center"><em>EluPro also granted clearance for indications beyond CIEDs, including neurostimulators and neuromodulators used for pain management, epilepsy, incontinence, and sleep apnea</em></p> <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA). http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html Mon, 17 Jun 2024 08:00:00 -0400 A.03607790 A.06822034 AZYO ELUT O.20026344 O.20147506 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html <p align="center"><em>EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market</em><br/></p> <p align="center"><em>EluPro also granted clearance for indications beyond CIEDs, including neurostimulators and neuromodulators used for pain management, epilepsy, incontinence, and sleep apnea</em></p> <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA). http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html Mon, 17 Jun 2024 08:00:00 -0400 A.03607790 A.06822034 AZYO ELUT O.20026344 O.20147506 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html <p align="center"><em>EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market</em><br/></p> <p align="center"><em>EluPro also granted clearance for indications beyond CIEDs, including neurostimulators and neuromodulators used for pain management, epilepsy, incontinence, and sleep apnea</em></p> <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA). http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html Mon, 17 Jun 2024 08:00:00 -0400 A.03607790 A.06822034 AZYO ELUT O.20026344 O.20147506 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html <p align="center"><em>EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market</em><br/></p> <p align="center"><em>EluPro also granted clearance for indications beyond CIEDs, including neurostimulators and neuromodulators used for pain management, epilepsy, incontinence, and sleep apnea</em></p> <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA). http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html Mon, 17 Jun 2024 08:00:00 -0400 A.03607790 A.06822034 AZYO ELUT O.20026344 O.20147506 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html <p align="center"><em>EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market</em><br/></p> <p align="center"><em>EluPro also granted clearance for indications beyond CIEDs, including neurostimulators and neuromodulators used for pain management, epilepsy, incontinence, and sleep apnea</em></p> <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA). http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html Mon, 17 Jun 2024 08:00:00 -0400 A.03607790 A.06822034 AZYO ELUT O.20026344 O.20147506 O.31701438 http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html <p align="center"><em>EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market</em><br/></p> <p align="center"><em>EluPro also granted clearance for indications beyond CIEDs, including neurostimulators and neuromodulators used for pain management, epilepsy, incontinence, and sleep apnea</em></p> <p align="justify">SILVER SPRING, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA). http://www.streetinsider.com/Press+Releases/Elutia+Announces+FDA+Clearance+of+EluPro%C2%AE%3A+The+First+Antibiotic-Eluting+BioEnvelope+Designed+to+Protect+Patients+with+Implantable+Cardiac+Pacemakers+and+Defibrillators/23364044.html Mon, 17 Jun 2024 08:00:00 -0400 A.03607790 A.06822034 AZYO ELUT O.20026344 O.20147506 O.31701438